Research: ALMUSHATAT and co-workers,

Listed in Issue 134

Abstract

ALMUSHATAT and co-workers, University Department of Surgery, Royal Infirmary, Glasgow, UK, have studied antioxidant vitamins, lipid peroxidation, and the systemic inflammatory response in patients with prostate cancer.

Background

The aim of this study was to examine the relationship between antioxidant vitamins, lipid peroxidation, disease stage and the systemic inflammatory response and patients with prostate cancer.

Methodology

14 healthy subjects, 20 patients with benign prostate hyperplasia, 40 patients with localized prostate cancer, and 38 patients with metastatic prostate cancer were enrolled in this biochemical study.

Results

Prostate cancer patients had higher concentrations of the lipid peroxidation product, malondialdehyde (p < 0.05), and lower circulating concentrations of lutein (p < 0.05), lycopene (p < 0.001) and beta-carotene (p < 0.05). Patients with metastatic prostate cancer, when compared with patients having localized disease, had lower concentrations of prostate-specific antigen (p < 0.05), vitamin E (p < or = 0.05), retinol (p < 0.01), lutein (p < 0.05) and lycopene (p < 0.01). In the prostate cancer patients, prostate-specific antigen was correlated with the concentrations of the lipid peroxidation product, malondialdehyde (rs= 0.353, p = 0.002). C-reactive protein was not correlated with the vitamin antioxidants nor malondialdehyde. In contrast, there was a negative correlation between malondialdehyde concentrations and both lutein (rs= -0.263, p = 0.020) and lycopene (rs= -0.269, p = 0.017).

Conclusion

These results indicate that lower concentrations of carotenoids, particularly lycopene (the main carotenoid in tomatoes), reflect disease progression rather than the systemic inflammatory response in patients with prostate cancer.

References

Almushatat AS, Talwar D, McArdle PA, Williamson C, Sattar N, O’Reilly DS, Underwood MA, McMillan DC. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. International Journal of Cancer 118 (4): 1051-1053, Feb 15, 2006.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page